Roger Wyndham

616 total citations
9 papers, 110 citations indexed

About

Roger Wyndham is a scholar working on Nephrology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roger Wyndham has authored 9 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roger Wyndham's work include Pharmacological Effects and Toxicity Studies (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). Roger Wyndham is often cited by papers focused on Pharmacological Effects and Toxicity Studies (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). Roger Wyndham collaborates with scholars based in Australia and United States. Roger Wyndham's co-authors include Steven Kalowski, J. R. Lawrence, C. R. P. George, Michael J. Field, Betty P.C. Lin, Carol A. Pollock, Grahame J. Elder, David A. Waugh, Gregory J. P. Perry and Gregory Perry and has published in prestigious journals such as Kidney International, The Medical Journal of Australia and QJM.

In The Last Decade

Roger Wyndham

8 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger Wyndham Australia	7	48	26	23	22	22	9	110
Ban Zhao China	9	39 0.8×	30 1.2×	33 1.4×	12 0.5×	15 0.7×	20	144
Hermann-Josef Groene Germany	8	45 0.9×	27 1.0×	20 0.9×	28 1.3×	14 0.6×	12	120
Kristian Kunz France	4	23 0.5×	26 1.0×	8 0.3×	23 1.0×	16 0.7×	7	88
DC Wheeler United Kingdom	6	36 0.8×	33 1.3×	14 0.6×	20 0.9×	34 1.5×	20	129
Ricong Xu China	8	103 2.1×	17 0.7×	38 1.7×	13 0.6×	14 0.6×	20	178
Anton Sabashnikov United Kingdom	7	51 1.1×	24 0.9×	11 0.5×	68 3.1×	14 0.6×	14	145
Helena Jardim Portugal	5	60 1.3×	15 0.6×	43 1.9×	14 0.6×	9 0.4×	9	135
Gary Walters United Kingdom	6	20 0.4×	53 2.0×	39 1.7×	14 0.6×	28 1.3×	6	168
Kenichiro Shigemoto Japan	10	117 2.4×	30 1.2×	21 0.9×	50 2.3×	14 0.6×	34	206
Lianqin Sun China	7	79 1.6×	19 0.7×	19 0.8×	10 0.5×	15 0.7×	16	135

Countries citing papers authored by Roger Wyndham

Since Specialization

Citations

This map shows the geographic impact of Roger Wyndham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Wyndham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Wyndham more than expected).

Fields of papers citing papers by Roger Wyndham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Wyndham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Wyndham. The network helps show where Roger Wyndham may publish in the future.

Co-authorship network of co-authors of Roger Wyndham

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Wyndham. A scholar is included among the top collaborators of Roger Wyndham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Wyndham. Roger Wyndham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Cheung, Grace W.C., Gary Chew, Roger Wyndham, Matthew Peters, & Sean Riminton. (2007). Myeloperoxidase‐antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl‐70‐positive scleroderma. Internal Medicine Journal. 37(3). 205–207. 7 indexed citations

Wilson, Stephanie H., David S. Celermajer, Akihiro Nakagomi, et al.. (1999). Vascular risk factors correlate to the extent as well as the severity of coronary atherosclerosis. Coronary Artery Disease. 10(7). 449–454. 14 indexed citations

Pollock, Carol A., Roger Wyndham, Grahame J. Elder, et al.. (1994). Effects of erythropoietin therapy on the lipid profile in end-stage renal failure. Kidney International. 45(3). 897–902. 33 indexed citations

Frewin, D. B., Lindsey Wilson, E. F. O'Sullivan, et al.. (1991). Felodipine in combination with a ?-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. European Journal of Clinical Pharmacology. 41(5). 393–396. 2 indexed citations

Perry, Gregory J. P., Roger Wyndham, Betty P.C. Lin, & Steven Kalowski. (1989). FIBRILLARY GLOMERULONEPHRITIS – A REPORT OF TWO CASES. Australian and New Zealand Journal of Medicine. 19(3). 250–253. 10 indexed citations

Perry, Gregory, C. R. P. George, Michael J. Field, et al.. (1989). Thin‐membrane nephropathy — a common cause of glomerular haematuria. The Medical Journal of Australia. 151(11-12). 638–642. 21 indexed citations

Wyndham, Roger. (1987). Influence of Renin Levels on the Treatment of Essential Hypertension With Thiazide Diuretics. Archives of Internal Medicine. 147(6). 1021–1021. 6 indexed citations

Dunstan, Colin R., E Hills, A. W. Norman, et al.. (1985). The Pathogenesis of Renal Osteodystrophy: Role of Vitamin D, Aluminium, Parathyroid Hormone, Calcium and Phosphorus. QJM. 55(217). 127–44. 15 indexed citations

Tiller, David J., et al.. (1975). Aortic Valve Replacement Following Cadaver Renal Transplantation. Australian and New Zealand Journal of Medicine. 5(2). 154–155. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact